Adamas to Present at Upcoming SVB Leerink CNS Forum
EMERYVILLE, Calif.--(BUSINESS WIRE)--Jun 23, 2021--
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the company will present “What’s Happening in Parkinson’s Disease & the GOCOVRI Opportunity” at the SVB Leerink CNS Forum on Tuesday, June 29 th at 1:10 pm Eastern Time.
The presentation will be broadcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. Replays of the event will be available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.
Source: Adamas Pharmaceuticals, Inc.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210623005941/en/
Vice President, Corporate Communications
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Adamas Pharmaceuticals, Inc.
Copyright Business Wire 2021.
PUB: 06/23/2021 04:42 PM/DISC: 06/23/2021 04:42 PM